What is Eli Health?
Eli Health is a pioneering health technology firm that has developed the Hormometer, an innovative system designed to provide real-time, actionable data on hormone levels. By offering instant testing for cortisol, progesterone, and testosterone, the company addresses a significant gap in the consumer health market for accessible, evidence-based diagnostics. With a robust intellectual property portfolio comprising over 12 patents, Eli Health is transforming how individuals manage their hormonal patterns. The company's focus on high-accuracy, rapid-result testing aligns with the broader industry shift toward decentralized, user-centric health management, enabling users to make informed, data-driven decisions regarding their daily wellness and long-term health outcomes.
How much funding has Eli Health raised?
Eli Health has raised a total of $6.3M across 3 funding rounds:
Angel/Seed
$1.5M
Angel/Seed
$3.7M
Stock/Share Issuance
$1.1M
Angel/Seed (2021): $1.5M with participation from Panache Ventures, Ramen Ventures, 2048 Ventures, Real Ventures, Techstars, and Vectr Ventures Limited
Angel/Seed (2023): $3.7M led by Garage Capital, Cake Ventures, and Muse Capital
Stock/Share Issuance (2025): $1.1M, investors not publicly disclosed
Key Investors in Eli Health
Garage Capital
A venture capital firm dedicated to helping Canadian and Y Combinator startups transition from early-stage development to growth through experienced-based operational advice.
Cake Ventures
A pre-seed and seed venture capital firm that invests in companies addressing demographic changes, with a specific focus on health, wellness, and technology solutions.
Muse Capital
An early-stage venture capital firm focused on investing in overlooked and untapped consumer technology opportunities in the sectors of care, play, and living.
What's next for Eli Health?
With this major strategic investment, Eli Health is well-positioned to transition from its initial development phase into a period of aggressive market expansion. The company is expected to utilize these funds to enhance its diagnostic accuracy, broaden its testing capabilities, and scale its distribution channels to meet the rising demand for personalized health insights. As the firm continues to refine its technology, the focus will likely shift toward integrating its data-rich platform into broader digital health ecosystems. By maintaining its commitment to scientific rigor and user accessibility, Eli Health is poised to capture a significant share of the burgeoning hormone monitoring market, setting a new standard for how consumers interact with their biological data.
See full Eli Health company page
